Pharmsville Valuation
| 318010 Stock | KRW 3,575 45.00 1.27% |
At this time, the company appears to be overvalued. Pharmsville holds a recent Real Value of W3078.96 per share. The prevailing price of the company is W3575.0. Our model determines the value of Pharmsville from analyzing the company fundamentals such as Operating Margin of 0.09 %, return on equity of 5.4, and Shares Owned By Insiders of 70.62 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Pharmsville's price fluctuation is very steady at this time. Calculation of the real value of Pharmsville is based on 3 months time horizon. Increasing Pharmsville's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Pharmsville is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pharmsville Stock. However, Pharmsville's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3575.0 | Real 3078.96 | Hype 3575.0 |
The real value of Pharmsville Stock, also known as its intrinsic value, is the underlying worth of Pharmsville Company, which is reflected in its stock price. It is based on Pharmsville's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Pharmsville's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Pharmsville Co helps investors to forecast how Pharmsville stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharmsville more accurately as focusing exclusively on Pharmsville's fundamentals will not take into account other important factors: Pharmsville Total Value Analysis
Pharmsville Co is presently forecasted to have takeover price of 61.69 B with market capitalization of 87.3 B, debt of 5.35 B, and cash on hands of 14.03 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Pharmsville fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
61.69 B | 87.3 B | 5.35 B | 14.03 B |
Pharmsville Investor Information
About 71.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Pharmsville's historical financial statements, Pharmsville Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Pharmsville Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Pharmsville has an asset utilization ratio of 52.52 percent. This suggests that the Company is making W0.53 for each dollar of assets. An increasing asset utilization means that Pharmsville Co is more efficient with each dollar of assets it utilizes for everyday operations.Pharmsville Ownership Allocation
The market capitalization of Pharmsville is W87.3 Billion. Pharmsville holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 70.62 pct. of Pharmsville outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.Pharmsville Profitability Analysis
The company reported the revenue of 39.03 B. Net Income was 5 B with profit before overhead, payroll, taxes, and interest of 27.43 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Pharmsville's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Pharmsville and how it compares across the competition.
About Pharmsville Valuation
The stock valuation mechanism determines Pharmsville's current worth on a weekly basis. Our valuation model uses a comparative analysis of Pharmsville. We calculate exposure to Pharmsville's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pharmsville's related companies.Pharmsville Co., Ltd. produces and sells functional health foods in South Korea. Pharmsville Co., Ltd. was founded in 2000 and headquartered in Seoul. Pharmsville is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Pharmsville's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Pharmsville's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pharmsville's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pharmsville's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pharmsville's revenue streams: Identify Pharmsville's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pharmsville's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pharmsville's growth potential: Evaluate Pharmsville's management, business model, and growth potential.
- Determine Pharmsville's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pharmsville's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Pharmsville Stock analysis
When running Pharmsville's price analysis, check to measure Pharmsville's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmsville is operating at the current time. Most of Pharmsville's value examination focuses on studying past and present price action to predict the probability of Pharmsville's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmsville's price. Additionally, you may evaluate how the addition of Pharmsville to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |